Title:
高脂血症を処置するためのＰＣＳＫ９阻害剤の使用
Document Type and Number:
Japanese Patent JP6846931
Kind Code:
B2
Abstract:
The present invention provides methods for treating hyperlipidemia in patients who are not on statin therapy. The methods of the present invention comprise administering to a patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody such as the exemplary antibody referred to herein as mAb316P.
Inventors:
Marie Baccarat-Dinette
Laurence Besac
Woomesh Saudari
Corinne Annoton
Robert Sea Podie
William Jay Sacira
Daniel A. Schwenmer Jaipe
Laurence Besac
Woomesh Saudari
Corinne Annoton
Robert Sea Podie
William Jay Sacira
Daniel A. Schwenmer Jaipe
Application Number:
JP2016521604A
Publication Date:
March 24, 2021
Filing Date:
October 10, 2014
Export Citation:
Assignee:
REGENERON PHARMACEUTICALS, INC.
International Classes:
A61K39/395; A61K31/192; A61K31/202; A61K31/337; A61K31/455; A61K31/785; A61P3/06; A61P43/00
Foreign References:
| WO2013039969A1 |
Other References:
N.Engl.J.MED.,2012,Vol.366, No.12, pp.1108-1118
JAMA,2012,Vol.308, No.23, pp.E1-E10
Drugs of the Future,2012,Vol.37, No.5,pp.331-341
WayBackMachineによる「http://www.clinicaltrials.gov/ct2/show/NCT1709513」の2013年7月3日のアーカイブ [online]、[検索日:2020年6月15日]、URL
JAMA,2012,Vol.308, No.23, pp.E1-E10
Drugs of the Future,2012,Vol.37, No.5,pp.331-341
WayBackMachineによる「http://www.clinicaltrials.gov/ct2/show/NCT1709513」の2013年7月3日のアーカイブ [online]、[検索日:2020年6月15日]、URL
Attorney, Agent or Firm:
Junji Yuda
Noriyuki Takebayashi
Noriyuki Takebayashi